Cubist Pharmaceuticals Inc news

   Watch this stock
Showing stories 11 - 20 of about 76   

Articles published

CBST 68.65 -0.38 (-0.55%)
price chart
News Buzz : Cubist Pharmaceuticals Inc. (NASDAQ:CBST), China Yuchai ...
Cubist Pharmaceuticals Inc. (NASDAQ:CBST) announced, it is recalling 101 production lots of its antibiotic Cubicin (daptomycin injection) amid fear of glass particles being present in the drug.
Related articles »  
Top News: Cubist Pharmaceuticals (NASDAQ:CBST), Taiwan Semiconductor ...
Cubist Pharmaceuticals, Inc. (NASDAQ:CBST) announced that Mike Bonney, Cubist's CEO, will present at the Morgan Stanley Global Healthcare Conference on Monday, September 8, to discuss the company's business activities, financial outlook, and current ...
Stock Runners � Cubist Pharmaceuticals, (NASDAQ:CBST), HomeAway ...  Techsonian (press release)
Related articles »  
Investors Are Watching: Cubist Pharmaceuticals (NASDAQ:CBST), Medivation ...
TheStreet Quant Ratings rates Cubist Pharmaceuticals Inc. (NASDAQ:CBST) as a hold. The company's strengths can be seen in multiple areas, such as its revenue growth, growth in earnings per share and expanding profit margins.
Watch List: IXYS Corp. (NASDAQ:IXYS), Cubist Pharmaceuticals (NASDAQ ...
Cubist Pharmaceuticals Inc. (NASDAQ:CBST) has announced it is voluntarily recalling nine lots of CUBICIN (daptomycin for injection) to the user level following complaints of foreign particulate matter in reconstituted vials.
News Buzz- Cubist Pharmaceuticals Inc (NASDAQ:CBST), Broadridge Financial ...
Cubist Pharmaceuticals Inc (NASDAQ:CBST) reported a surge of +0.97%, after opening at the price of $68.20. Its closing price for the day was $68.91.
Stocks Buzz - Cubist Pharmaceuticals Inc (NASDAQ:CBST) , WPX Energy Inc ...
Cubist Pharmaceuticals Inc (NASDAQ:CBST) recentlyinformed that Mike Bonney, Cubist's CEO, will present at the Morgan Stanley Global Healthcare Conference on Monday, September 8, to discuss the company's business activities, financial outlook, and ...
Related articles »  
Investors Are Watching : Yahoo! Inc. (NASDAQ:YHOO), Science Applications ...
The European Medicines Agency (EMA) accepted Cubist Pharmaceuticals, Inc . (NASDAQ:CBST)'s Marketing Authorization Application (MAA) for its investigational antibiotic, ceftolozane/tazobactam.
TransCelerate BioPharma Inc. Releases Recommended Approach for Protecting ...
Additional members that have joined since the inception of TransCelerate include Allergan, Inc., Astellas Pharma Inc., Biogen Idec, Cubist Pharmaceuticals, EMD Serono, Inc. (a subsidiary of Merck KGaA, Darmstadt, Germany), Forest Research Institute (a ...
Related articles »  
Cubist Pharmaceuticals (CBST) Marked As A Barbarian At The Gate
Editor's Note: Any reference to TheStreet Ratings and its underlying recommendation does not reflect the opinion of TheStreet, Inc. or any of its contributors including Jim Cramer or Stephanie Link. Trade-Ideas LLC identified Cubist Pharmaceuticals ...
Related articles »  
Cubist to Present at Morgan Stanley Global Healthcare Conference
Cubist Pharmaceuticals, Inc. is a biopharmaceutical company focused on the research, development, and commercialization of pharmaceutical products that address significant unmet medical needs in the acute care environment.
Related articles »